Finished
IS-002 Phase 2 Prostate Cancer Study
NCT05946603 · Intuitive Surgical · Updated 4 Sept 2025
- What is being tested
- Administration of IS-002; Firefly fluorescent imaging; robotic-assisted laparoscopic prostatectomy with pelvic lymph node dissection
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years to 75 years. About 59 people. The full rules are on the registry page.
- Where
- United States (4 sites)
- When
- Starts or started 16 June 2023, ends 23 May 2025. Registered 14 July 2023.
- Results
- None posted yet.
In the researchers' words
Phase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared (NIR) fluorescence imaging, for identification of prostate cancer during robotic-assisted radical prostatectomy (RARP) with (extended) pelvic lymph node dissection ((e)PLND) using the da Vinci® X/Xi Surgical System with Firefly® Fluorescence Imaging.
Sites
- UCSFSan Francisco, California, United States
- Johns HopkinsBaltimore, Maryland, United States
- Mayo ClinicRochester, Minnesota, United States
- MSKCCNew York, New York, United States